BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Home » Authors » Cornelia Zou

Articles by Cornelia Zou

'Very complex issue': Australian tax inquiry calls big pharma to floor

July 8, 2015
By Cornelia Zou
HONG KONG – A series of enquiries in Australia into tax payments by multinational pharmaceutical companies is likely to have little impact on their operations, particularly outside the country, despite the concern of authorities there.
Read More

'Very complex issue': Australian tax inquiry calls big pharma to floor

July 8, 2015
By Cornelia Zou
HONG KONG – A series of enquiries in Australia into tax payments by multinational pharmaceutical companies is likely to have little impact on their operations, particularly outside the country, despite the concern of authorities there.
Read More

Singapore investor joins consortium for majority stake in Asia-expanding Alvogen

June 24, 2015
By Cornelia Zou
HONG KONG – A group of investors, including one from Singapore, have acquired a majority stake in Iceland-based biosimilar and generics maker Alvogen Inc. The company has been expanding both its expertise in biotech and its presence in Asia-Pacific.
Read More

China's rejection of Sovaldi patent 'not the end of the story'

June 24, 2015
By Cornelia Zou and Marie Powers
Word leaked out late last week of China's rejection of a patent application by Gilead Sciences Inc. related to the blockbuster hepatitis C virus (HCV) drug, Sovaldi (sofosbuvir), putting a damper – at least for now – on the company's scheme to introduce one of its top-selling drugs into the world's most populous country.
Read More

Industry awaits Australia DNA patent ruling

June 24, 2015
By Cornelia Zou and Mari Serebrov
HONG KONG – The life sciences industry is watching closely to see if Australia follows the U.S. lead in rejecting patent claims involving isolated DNA.
Read More

Rumors of mass exodus from China were just that

June 24, 2015
By Cornelia Zou
HONG KONG – Claims last year that the Chinese market was due for a massive exodus, particularly in the biotech space, may have been somewhat premature. Both international and domestic investors are actively betting on the country's pharmaceutical sector.
Read More

Singapore investor joins consortium for majority stake in Asia-expanding Alvogen

June 24, 2015
By Cornelia Zou
HONG KONG – A group of investors, including one from Singapore, have acquired a majority stake in Iceland-based biosimilar and generics maker Alvogen Inc.
Read More

Industry awaits Australia DNA patent ruling

June 23, 2015
By Cornelia Zou
HONG KONG – The life sciences industry is watching closely to see if Australia follows the U.S. lead in rejecting patent claims involving isolated DNA.
Read More

China's rejection of Sovaldi patent 'not the end of the story'

June 23, 2015
By Cornelia Zou
Word leaked out late last week of China's rejection of a patent application by Gilead Sciences Inc. related to the blockbuster hepatitis C virus (HCV) drug, Sovaldi (sofosbuvir), putting a damper – at least for now – on the company's scheme to introduce one of its top-selling drugs into the world's most populous country.
Read More

Asia in the Spotlight: Osmunda med-tech CRO benefiting from changes to China's regulatory systems

June 22, 2015
By Cornelia Zou
Previous 1 2 … 22 23 24 25 26 27 28 29 30 … 56 57 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing